, PAX7.pos.norm F1184.FFPE.PAX3.pos.norm F1180.FROZEN.PAX3.pos F1140.FROZEN.PAX3.pos F1063.FROZEN.PAX.Neg F849.FROZEN.PAX7.pos

L. B. Rozeman, A. M. Cleton-jansen, and P. C. Hogendoorn, Pathology of primary malignant bone and cartilage tumours, International Orthopaedics, vol.30, issue.6, pp.437-444, 2006.

S. Ferrari and E. Palmerini, Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma, Current Opinion in Oncology, vol.19, issue.4, pp.341-346, 2007.

A. J. Chou and R. Gorlick, Chemotherapy resistance in osteosarcoma: current challenges and future directions, Expert Review of Anticancer Therapy, vol.6, issue.7, pp.1075-1085, 2006.

F. G. Barr, N. Galili, J. Holick, J. A. Biegel, G. Rovera et al., Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma, Nature Genetics, vol.3, issue.2, pp.113-117, 1993.

R. J. Davis, C. M. Cruz, M. A. Lovell, J. A. Biegel, and F. G. Barr, Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma, Cancer Research, vol.54, issue.11, pp.2869-2872, 1994.

P. H. Sorensen, J. C. Lynch, and S. J. Qualman, PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group, Journal of Clinical Oncology, vol.20, issue.11, pp.2672-2679, 2002.

D. Williamson, E. Missiaglia, and A. De-reyniès, Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma, Journal of Clinical Oncology, vol.28, issue.13, pp.2151-2158, 2010.

A. Esquela-kerscher and F. J. Slack, Oncomirs-microRNAs with a role in cancer, Nature Reviews Cancer, vol.6, issue.4, pp.259-269, 2006.

G. Hutvágner and P. D. Zamore, A microRNA in a multipleturnover RNAi enzyme complex, Science, vol.297, issue.5589, pp.2056-2060, 2002.

Y. Lee, C. Ahn, and J. Han, The nuclear RNase III Drosha initiates microRNA processing, Nature, vol.425, issue.6956, pp.415-419, 2003.

J. G. Doench and P. A. Sharp, Specificity of microRNA target selection in translational repression, Genes and Development, vol.18, issue.5, pp.504-511, 2004.

Z. Li, M. Q. Hassan, and M. Jafferji, Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation, Journal of Biological Chemistry, vol.284, issue.23, pp.15676-15684, 2009.

T. Sugatani and K. A. Hruska, MicroRNA-223 is a key factor in osteoclast differentiation, Journal of Cellular Biochemistry, vol.101, issue.4, pp.996-999, 2007.

K. Chen and N. Rajewsky, Natural selection on human microRNA binding sites inferred from SNP data, Nature Genetics, vol.38, issue.12, pp.1452-1456, 2006.

J. Lu, G. Getz, and E. A. Miska, MicroRNA expression profiles classify human cancers, Nature, vol.435, issue.7043, pp.834-838, 2005.

S. Volinia, G. A. Calin, and C. G. Liu, A microRNA expression signature of human solid tumors defines cancer gene targets, Proceedings of the National Academy of Sciences of the United States of America, vol.103, pp.2257-2261, 2006.

G. A. Calin, M. Ferracin, and A. Cimmino, A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia, New England Journal of Medicine, vol.353, issue.17, pp.1793-1801, 2005.

A. Israel, R. Sharan, E. Ruppin, and E. Galun, Increased microRNA activity in human cancers, PLoS One, vol.4, issue.6, 2009.

S. Subramanian, W. O. Lui, and C. H. Lee, MicroRNA expression signature of human sarcomas, Oncogene, vol.27, issue.14, pp.2015-2026, 2008.

J. C. Wittig, J. Bickels, and D. Priebat, Osteosarcoma: a multidisciplinary approach to diagnosis and treatment, American Family Physician, vol.65, issue.6, pp.1123-1136, 2002.

A. Dutour, D. Leclers, and J. Monteil, Non-invasive imaging correlates with histological and molecular characteristics of an osteosarcoma model: application for early detection and follow-up of MDR phenotype, Anticancer Research, vol.27, issue.6B, pp.4171-4178, 2007.

A. Dutour, J. Monteil, and F. Paraf, Endostatin cDNA/cationic liposome complexes as a promising therapy to prevent lung metastases in osteosarcoma: study in a humanlike rat orthotopic tumor, Molecular Therapy, vol.11, issue.2, pp.311-319, 2005.

M. Allouche, H. G. Delbruck, and B. Klein, Malignant bone tumours induced by a local injection of colloidal radioactive 144Cerium in rats as a model for human osteosarcomas, International Journal of Cancer, vol.26, issue.6, pp.777-782, 1980.

K. Arakawa, N. Kono, Y. Yamada, H. Mori, and M. Tomita, KEGG-based pathway visualization tool for complex omics data, In Silico Biology, vol.5, issue.4, pp.419-423, 2005.

A. Gougelet, D. Pissaloux, and A. Besse, miRNA profiles in osteosarcoma as a predictive tool for ifosfamide chemotherapeutic treatment response, International Journal of Cancer

R. E. Brown, Morphoproteomic portrait of the mTOR pathway in mesenchymal chondrosarcoma, Annals of Clinical and Laboratory Science, vol.34, issue.4, pp.397-399, 2004.

Q. Zhou, Z. Deng, Y. Zhu, H. Long, S. Zhang et al., mTOR/p70S6K signal transduction pathway contributes to osteosarcoma progression and patients' prognosis, Medical Oncology, vol.27, issue.4, pp.1239-1245, 2010.

B. H. Jiang and L. Z. Liu, Role of mTOR in anticancer drug resistance: perspectives for improved drug treatment, Drug Resistance Updates, vol.11, issue.3, pp.63-76, 2008.

X. Wan, A. Mendoza, C. Khanna, and L. J. Helman, Rapamycin inhibits ezrin-mediated metastatic behavior in a murine model of osteosarcoma, Cancer Research, vol.65, issue.6, pp.2406-2411, 2005.

I. Beuvink, A. Boulay, and S. Fumagalli, The mTOR inhibitor RAD001 sensitizes tumor cells to DNA-damaged induced apoptosis through inhibition of p21 translation, Cell, vol.120, issue.6, pp.747-759, 2005.

S. Mabuchi, D. A. Altomare, and D. C. Connolly, RAD001 (Everolimus) delays tumor onset and progression in a transgenic mouse model of ovarian cancer, Cancer Research, vol.67, issue.6, pp.2408-2413, 2007.

S. Ambs, R. L. Prueitt, and M. Yi, Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer, Cancer Research, vol.68, issue.15, pp.6162-6170, 2008.

G. A. Calin, M. Ferracin, and A. Cimmino, A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia, New England Journal of Medicine, vol.353, issue.17, pp.1793-1801, 2005.

A. J. Schetter, S. Y. Leung, and J. J. Sohn, MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma, Journal of the American Medical Association, vol.299, issue.4, pp.425-436, 2008.

S. L. Yu, H. Y. Chen, and G. C. Chang, MicroRNA signature predicts survival and relapse in lung cancer, Cancer Cell, vol.13, issue.1, pp.48-57, 2008.

B. Song, Y. Wang, and Y. Xi, Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells, Oncogene, vol.28, issue.46, pp.4065-4074, 2009.

R. Taulli, F. Bersani, and V. Foglizzo, The musclespecific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation, Journal of Clinical Investigation, vol.119, issue.8, pp.2366-2378, 2009.

R. N. Veedu and J. Wengel, Locked nucleic acids: promising nucleic acid analogs for therapeutic applications, Chemistry and Biodiversity, vol.7, issue.3, pp.536-542, 2010.

J. A. Fletcher, M. C. Gebhardt, and H. P. Kozakewich, Cytogenetic aberrations in osteosarcomas: nonrandom deletions, rings, and double-minute chromosomes, Cancer Genetics and Cytogenetics, vol.77, issue.1, pp.81-88, 1994.

L. Han, P. D. Witmer, E. Casey, D. Valle, and S. Sukumar, DNA methylation regulates microRNA expression, Cancer Biology and Therapy, vol.6, issue.8, pp.1284-1288, 2007.

Y. Saito and P. A. Jones, Epigenetic activation of tumor suppressor microRNAs in human cancer cells, Cell Cycle, vol.5, issue.19, pp.2220-2222, 2006.

I. Bray, K. Bryan, and S. Prenter, Widespread dysregulation of MiRNAs by MYCN amplification and chromosomal imbalances in neuroblastoma: association of miRNA expression with survival, PLoS One, vol.4, issue.11, 2009.

S. Mi, Z. Li, and P. Chen, Aberrant overexpression and function of the miR-17-92 cluster in MLL-rearranged acute leukemia, Proceedings of the National Academy of Sciences of the United States of America, vol.107, pp.3710-3715, 2010.

S. Selvarajah, M. Yoshimoto, and O. Ludkovski, Genomic signatures of chromosomal instability and osteosarcoma progression detected by high resolution array CGH and interphase FISH, Cytogenetic and Genome Research, vol.122, issue.1, pp.5-15, 2008.

M. Wachtel, M. Dettling, and E. Koscielniak, Gene expression signatures identify rhabdomyosarcoma subtypes and detect a novel t(2;2)(q35;p23) translocation fusing PAX3 to NCOA1, Cancer Research, vol.64, issue.16, pp.5539-5545, 2004.

E. Davicioni, F. G. Finckenstein, V. Shahbazian, J. D. Buckley, T. J. Triche et al., Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomas, Cancer Research, vol.66, issue.14, pp.6936-6946, 2006.

A. B. Hui, W. Shi, and P. C. Boutros, Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues, Laboratory Investigation, vol.89, issue.5, pp.597-606, 2009.

K. R. Leite, J. M. Canavez, and S. T. Reis, miRNA analysis of prostate cancer by quantitative real time PCR: comparison between formalin-fixed paraffin embedded and fresh-frozen tissue, Urologic Oncology: Seminars and Original Investigations

A. Liu, M. T. Tetzlaff, and P. Vanbelle, MicroRNA expression profiling outperforms mRNA expression profiling in formalin-fixed paraffin-embedded tissues, International Journal of Clinical and Experimental Pathology, vol.2, issue.6, pp.519-527, 2009.

X. Chen, Y. Ba, and L. Ma, Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases, Cell Research, vol.18, issue.10, pp.997-1006, 2008.

P. S. Mitchell, R. K. Parkin, and E. M. Kroh, Circulating microRNAs as stable blood-based markers for cancer detection, Proceedings of the National Academy of Sciences of the United States of America, vol.105, pp.10513-10518, 2008.